CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of C$3.75 and traded as low as C$3.41. CanSino Biologics shares last traded at C$3.41, with a volume of 1,300 shares trading hands.
CanSino Biologics Price Performance
The firm’s fifty day moving average price is C$3.99 and its 200-day moving average price is C$3.73.
About CanSino Biologics
CanSino Biologics Inc is a China-based biotechnology company focused on the research, development, manufacturing and commercialization of vaccines. The company develops vaccine technologies intended to address infectious diseases, with activities spanning early-stage research, clinical development, regulatory approval and commercial production.
CanSino’s portfolio includes Convidecia, an adenovirus-based COVID-19 vaccine, and Convidecia Air, an inhaled version designed for respiratory immunization.
Recommended Stories
- Five stocks we like better than CanSino Biologics
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
